Status:

COMPLETED

Dose Escalation With Remicade® and Orencia®

Lead Sponsor:

Bristol-Myers Squibb

Conditions:

Rheumatoid Arthritis

Eligibility:

All Genders

18+ years

Brief Summary

The purpose of this study is to describe infliximab and abatacept dosing patterns (i.e., dosing amount and frequency) and costs among a population of managed care enrollees with RA. This study will al...

Detailed Description

This study will be conducted in two parts. The primary analysis is a longitudinal analysis, where patients' health care claims from a period during which the patient was continuously enrolled in the h...

Eligibility Criteria

Inclusion

  • Commercial health plan enrollees with medical and pharmacy coverage
  • At least 3 claims on separate days for infliximab (HCPCS J1745) or abatacept (HCPCS C9230, J0129, J3590) administration during the subject identification period
  • The 3 initial claims for abatacept occurred within a 6-week period inclusive of the index date and the three initial claims for infliximab occur within a 9-week period inclusive of the index date
  • Presence of a diagnosis of RA (ICD-9-CM 714.xx)
  • Continuous enrollment during the baseline and follow-up periods
  • At least 18 years of age or older on the index date

Exclusion

  • Prior exposure to the index medication during the baseline period
  • Diagnosis of psoriasis (ICD-9-CM 696.1), psoriatic arthritis (696.0), ankylosing spondylitis (720.0), Crohn's disease (555.x), or ulcerative colitis (556.x) in any position at any time during the study period
  • Exposure to alefacept (HCPCS J0215, C9211, C9212) or efalizumab (HCPCS S0162) at any time during the study period

Key Trial Info

Start Date :

January 1 2010

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

August 1 2010

Estimated Enrollment :

5451 Patients enrolled

Trial Details

Trial ID

NCT01141413

Start Date

January 1 2010

End Date

August 1 2010

Last Update

April 4 2012

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.

Dose Escalation With Remicade® and Orencia® | DecenTrialz